Targeted micelles with chemotherapeutics and gene drugs to inhibit the G1/S and G2/M mitotic cycle of prostate cancer
Abstract Background Chemotherapy and gene therapy are used in clinical practice for the treatment of castration-resistant prostate cancer. However, the poor efficiency of drug delivery and serious systemic side effects remain an obstacle to wider application of these drugs. Herein, we report newly d...
Main Authors: | Yiran Zhang, Yanming Wang, Li Meng, Qingqing Huang, Yueqi Zhu, Wenguo Cui, Yingsheng Cheng, Ranlu Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-020-00756-6 |
Similar Items
-
Exploring Polymeric Micelles for Improved Delivery of Anticancer Agents: Recent Developments in Preclinical Studies
by: Wei Fan, et al.
Published: (2013-03-01) -
Oligo(Lactic Acid)<sub>8</sub>-Docetaxel Prodrug-Loaded PEG-<i>b</i>-PLA Micelles for Prostate Cancer
by: Lauren Repp, et al.
Published: (2021-10-01) -
Micelles
Published: (1980) -
Styrene Maleic Acid Copolymer-Based Micellar Formation of Temoporfin (SMA@ mTHPC) Behaves as A Nanoprobe for Tumor-Targeted Photodynamic Therapy with A Superior Safety
by: Jun Fang, et al.
Published: (2021-10-01) -
Liposome-Micelle-Hybrid (LMH) Carriers for Controlled Co-Delivery of 5-FU and Paclitaxel as Chemotherapeutics
by: Md. Musfizur Hassan, et al.
Published: (2023-07-01)